(Q43618799)

25 November 2017

title

Increased intrathecal production of apolipoprotein D in multiple sclerosis (English)

1 reference

25 November 2017

0 references

1

1 reference

25 November 2017

Knipping G

2

1 reference

25 November 2017

Wicher I

3

1 reference

25 November 2017

Dilitz E

4

1 reference

25 November 2017

Egg R

5

1 reference

25 November 2017

Deisenhammer F

6

1 reference

25 November 2017

Berger T

7

1 reference

25 November 2017

publication date

1 October 2001

1 reference

Journal of Neuroimmunology

25 November 2017

published in

1 reference

25 November 2017

volume

119

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

327-332

1 reference

Potent stimulatory effect of interleukin-1 alpha on apolipoprotein D and gross cystic disease fluid protein-15 expression in human breast-cancer cells

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900378-2

7 January 2021

Increased expression of apolipoprotein D following experimental traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900378-2

7 January 2021

Quantification of apolipoprotein D by an immunoassay with time-resolved fluorescence spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900378-2

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900378-2

7 January 2021

Remyelination in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900378-2

7 January 2021

Plasma lipids and their fatty acid composition in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900378-2

7 January 2021

Pattern of apolipoprotein D immunoreactivity in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900378-2

7 January 2021

Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900378-2

7 January 2021

Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900378-2

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900378-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900378-2

1 reference

7 January 2021

Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900378-2

7 January 2021

Cellular cholesterol storage in the Niemann-Pick disease type C mouse is associated with increased expression and defective processing of apolipoprotein D.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900378-2

7 January 2021

Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900378-2

7 January 2021

Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900378-2

7 January 2021

Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900378-2

7 January 2021

10.1016/S0165-5728(01)00378-2

Identifiers

DOI

1 reference

25 November 2017

1 reference